About NovoGI
NovoGI is a company based in Netanya (Israel) founded in 1996 by Gavriel Meron. It operates as a B2B. NovoGI has raised $18.5 million across 1 funding round from investors including Forbion, Evergreen Venture Partners and Israel HealthCare Ventures. NovoGI operates in a competitive market with competitors including Axonics, Averto Medical, Boomerang Medical, Signum Surgical and MOWOOT, among others.
- Headquarter Netanya, Israel
- Founders Gavriel Meron
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.5 M (USD)
in 1 rounds
-
Latest Funding Round
$18.5 M (USD), Series B
Aug 11, 2009
-
Investors
Forbion
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovoGI
NovoGI has successfully raised a total of $18.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.5 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NovoGI
NovoGI has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Forbion, Evergreen Venture Partners and Israel HealthCare Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
Early-stage venture capital is provided to Israeli companies across sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for NovoGI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovoGI
Investment portfolio details for NovoGI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NovoGI
Detailed financials for NovoGI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novogi Comparisons
Peer comparison for NovoGI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NovoGI
NovoGI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Averto Medical, Boomerang Medical, Signum Surgical and MOWOOT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for autoimmune disease treatment.
|
|
| Locked | Locked | Locked |
Surgically implanted devices for perianal fistula treatment are provided.
|
|
| Locked | Locked | Locked |
A non-invasive medical device for chronic constipation treatment is developed.
|
Detailed competitors of NovoGI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novogi
Complete news archive for NovoGI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovoGI
NovoGI was founded in 1996 and raised its 1st funding round 13 years after it was founded.
NovoGI is headquartered in Netanya, Israel. It is registered at Netanya, Central District, Israel.
Gavriel Meron is the current CEO of NovoGI. They have also founded this company.
NovoGI is a funded company, having raised a total of $18.5M across 1 funding round to date.
NovoGI, based in Netanya, focuses on providing healthcare solutions, developing medical devices, surgical devices, and gi management. Provides compression anastomosis devices for GI disease management. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
NovoGI's top competitors include Axonics, Signum Surgical and Exero Medical.
NovoGI has 6 investors. Key investors include Forbion, Evergreen Venture Partners, Israel HealthCare Ventures, Alice Ventures, and SCP Vitalife.